High-Alert and Look-Alike Sound-Alike Medications: Introduction 101
SKS Medication Safety Series, Chapter 11 of 15 · Standard SİY10
Prof. Dr. Mehmet Nurullah Kurutkan, Düzce Üniversitesi İşletme Fakültesi Sağlık Yönetimi Bölümü
Chapter at a glance
A small number of medicines cause a large share of serious harm when something goes wrong, and many errors happen because two medicines look or sound alike. This chapter covers both groups and the safeguards hospitals use. It corresponds to SKS SİY10 on special medication groups (Sağlık Bakanlığı, 2020).
Evidence base: 310 records of a 4948-record Web of Science corpus on hospital medication safety (Section 7). Reading time: about 25 minutes. Prior knowledge required: none.
Learning objectives
After working through this chapter, the reader should be able to:
- list the special medication groups named in SKS SİY10;
- explain why high-alert medicines need extra safeguards;
- evaluate Tall Man lettering, labelling and storage separation for LASA drugs;
- summarise evidence on insulin, anticoagulant and opioid safety.
Key concepts
- High-alert medication: a drug with a heightened risk of significant harm when used in error
- Look-alike, sound-alike (LASA) drugs: drugs with similar names or packaging
- Tall Man lettering: capitals highlighting differences in similar names
- Concentrated electrolytes: for example concentrated potassium chloride
- Colour-coded labelling: visual cues for high-risk products
Contents: How this chapter was produced · 1. Introduction · 2. History and development · 3. Definitions and conceptual schema · 4. Distinguishing it from neighbouring concepts · 5. Types and classifications · 6. Theoretical frameworks and models · 7. Themes and bibliometric profile · 8. The situation in Türkiye · 9. Debates and contradictions in the literature · 10. Measurement problems · 11. Research gaps and agenda · 12. Implications for practice today · Summary · Discussion questions · Further reading · Glossary · References · Source verification and AI use statement · Data and supplementary material
How this chapter was produced
Box 1. Method
Database: Web of Science Core Collection (SCI-EXPANDED, SSCI, ESCI); English; articles and reviews (including early access). Search date: 16 November 2026; all years (1981 to 2027).
Search: (#1 medication safety and error terms AND #2 hospital settings AND #3 fifteen SKS content blocks) NOT #4 animal and preclinical terms; the full string is on the series hub.
Screening: five export files (4955 records) were merged; 7 duplicates were removed by WoS accession number, DOI and normalised title plus year, leaving 4948 records. Records were assigned to this sub-topic when its term set (high-alert or high-risk medication, look-alike, sound-alike, LASA, Tall Man, concentrated electrolytes, potassium chloride, insulin, anticoagulants, heparin, opioids) appeared in the title or keywords; a record can belong to several sub-topics. Included here: 310 records (204 with the term in the title; 51 reviews).
Limitations: single database; English only; assignment by term matching, checked by reading titles of the most cited and most recent records; claims are checked against abstracts, not full texts.
4955 records
204 title matches; 51 reviews
other chapters or general records
1. Introduction
SKS lists special medication groups including emergency paediatric drugs, look-alike and sound-alike drugs, psychotropics, narcotics, light-sensitive drugs, high-risk drugs, drugs requiring special preparation, concentrated electrolytes, drugs contraindicated in pregnancy and lactation, and cytotoxics (Sağlık Bakanlığı, 2020). Hospitals must prepare lists, keep them in use areas, place emergency paediatric, LASA and high-risk drugs in cabinets so as to prevent errors, and use warning labels such as colour coding for high-risk drugs without warning features (Sağlık Bakanlığı, 2020).
The concentration of harm is striking: a systematic review found that 30 drugs or drug classes caused 82% of serious medication errors, and that focusing on seven classes could potentially halve serious outcomes (Saedder et al., 2014).
2. History and development
Early records examined factors associated with preventable reactions (Pearson et al., 1994) and opioid dosing accuracy (Dunn & Wolfe, 2000). Classification of oxytocin (Simpson & Knox, 2009) and insulin (Cobaugh et al., 2013) as high-alert medications followed, with standardised protocols for sliding scale insulin (Donihi et al., 2006). In the LASA field, reviews of causes (Ciociano & Bagnasco, 2014) and labelling strategies (Larmené-Beld et al., 2018) appeared, and the effectiveness of Tall Man lettering was tested (Lohmeyer et al., 2023; Zhong et al., 2016). Machine learning decision support is now used to intercept wrong-drug and LASA errors (Chen et al., 2024).
- 1994 Factors associated with preventable ADRs (Pearson et al., 1994).
- 2006 Standard protocol reduces sliding scale insulin errors (Donihi et al., 2006).
- 2009 Oxytocin as a high-alert medication in perinatal care (Simpson & Knox, 2009).
- 2013 Expert consensus on insulin safety in hospitals (Cobaugh et al., 2013).
- 2014 Systematic review identifies high-risk medications (Saedder et al., 2014).
- 2016 Tall Man lettering not associated with fewer LASA errors in 42 hospitals (Zhong et al., 2016).
- 2024 ML-based decision support reduces wrong-drug and LASA errors (Chen et al., 2024).
3. Definitions and conceptual schema
| Source | Year | Discipline | Definition (paraphrased) | Emphasised dimension |
|---|---|---|---|---|
| Sağlık Bakanlığı, 2020 | 2020 | Accreditation standard | Special medication groups requiring lists, controlled placement and warning labels. | Lists and placement |
| Saedder et al., 2014 | 2014 | Clinical pharmacology | High-risk medications as the drug classes accounting for most serious medication errors. | Harm concentration |
| Cobaugh et al., 2013 | 2013 | Hospital pharmacy | Insulin as a high-alert drug requiring safeguards across the whole use process. | Process-wide safeguards |
| Ciociano & Bagnasco, 2014 | 2014 | Nursing | LASA errors as confusion caused by similarity of names or packages. | Similarity |
| Larmené-Beld et al., 2018 | 2018 | Human factors | Label design strategies such as Tall Man lettering and colour coding to avoid look-alike errors. | Perception |
certain medicines need extra barriers because errors with them are either more likely or more harmful
High-alert definitions emphasise consequences (Saedder et al., 2014); LASA definitions emphasise likelihood through similarity (Ciociano & Bagnasco, 2014). SKS groups both under special medicines (Sağlık Bakanlığı, 2020).
4. Distinguishing it from neighbouring concepts
This sub-topic overlaps with prescribing, interactions, administration and controlled drugs (Figure 4), reflecting, for example, that opioids are both high-alert and controlled.
| Neighbouring concept | How it differs |
|---|---|
| Controlled drugs (SİY11) | Legal control for abuse potential; high-alert status reflects harm in error (Sağlık Bakanlığı, 2020). |
| Storage (SİY04) | Placement rules for LASA drugs are part of storage (Ruutiainen et al., 2021). |
| Administration (SİY08) | Double checks are often required for high-alert drugs (Koyama et al., 2020). |
5. Types and classifications
Commonly studied high-alert groups in the corpus are insulin (Cobaugh et al., 2013), anticoagulants including direct oral anticoagulants (Al Rowily et al., 2022), opioids (Morton & Errera, 2010) and oxytocin (Simpson & Knox, 2009). LASA strategies include Tall Man lettering, colour coding, storage separation and software screening (Basco et al., 2010; Larmené-Beld et al., 2018).
6. Theoretical frameworks and models
Human factors theory of perception and attention supports labelling research (Lohmeyer et al., 2023). Stewardship concepts extend to anticoagulants, where an antithrombotic team improved guideline adherence (Dreijer et al., 2019).
7. Themes and bibliometric profile
Figure 5 shows a profile shaped by drug-specific research. Errors with direct oral anticoagulants were summarised in a meta-analysis that called for technology-facilitated and theory-based interventions (Al Rowily et al., 2022). Standardised protocols reduced insulin prescribing errors and hyperglycaemia (Donihi et al., 2006).
Records per year 2026 (incomplete)
Most frequent journals
Most frequent countries
Most frequent author keywords: medication errors (61), patient safety (47), medication safety (43), medication error (25), anticoagulants (24), insulin (16), hospital (15), opioids (15), adverse drug events (15), high-alert medications (14).
8. The situation in Türkiye
Three records have Turkish authors. A Turkish version of the High-Alert Medications Questionnaire showed acceptable reliability for assessing professionals’ knowledge (Öztürk et al., 2022), a study tested computerised decision support to prevent high-risk medication errors by paediatric nurses (Öztornaci & Basbakkal, 2026), and patients’ awareness of anticoagulant use in atrial fibrillation was assessed (Pirmammadova et al., 2026).
9. Debates and contradictions in the literature
Does Tall Man lettering work? In 42 children’s hospitals its implementation was not associated with fewer potential LASA errors (Zhong et al., 2016), yet an eye-tracking study showed that it changes visual attention and supports nurses in identifying syringe labels (Lohmeyer et al., 2023).
Lists or systems? Lists of high-alert drugs are widely used, but knowledge of them among nurses is limited (Zyoud et al., 2019), suggesting lists need training and system support.
Technology as a fix? Automated cabinets reduce LASA risk when used correctly but can increase it with shared compartments (Ruutiainen et al., 2021).
10. Measurement problems
LASA error rates are difficult to estimate; pharmacy data screening found lower rates than for other paediatric errors (Basco et al., 2010). Knowledge questionnaires measure readiness, not outcomes (Öztürk et al., 2022). Many studies use surrogate outcomes such as glucose values (Donihi et al., 2006).
11. Research gaps and agenda
- Which combination of labelling and storage reduces LASA errors in real settings? (Larmené-Beld et al., 2018; Zhong et al., 2016)
- Do SKS colour-coding rules reduce high-alert errors in Turkish hospitals? (no study found)
- How can nurses’ knowledge of high-alert drugs be improved and sustained? (Öztürk et al., 2022; Zyoud et al., 2019)
- What is the role of ML decision support for LASA interception? (Chen et al., 2024)
- Which anticoagulant stewardship models work best? (Dreijer et al., 2019)
12. Implications for practice today
Keep a short, local high-alert list based on harm data (Saedder et al., 2014); separate LASA products physically and in cabinets (Ruutiainen et al., 2021); use standard protocols for insulin (Cobaugh et al., 2013; Donihi et al., 2006); train staff with validated tools (Öztürk et al., 2022); and test label changes before roll-out (Lohmeyer et al., 2023).
Summary
- A small number of drug classes cause most serious errors.
- SKS SİY10 requires lists, placement and warning labels.
- Evidence on Tall Man lettering is mixed.
- Protocols and stewardship improve insulin and anticoagulant safety.
- Turkish work includes a validated knowledge questionnaire.
Discussion questions
- Why do high-alert medicines need different safeguards from LASA drugs?
- Interpret the conflicting findings on Tall Man lettering.
- Design a cabinet layout for LASA pairs on a paediatric ward.
- How would you evaluate a colour-coding policy?
- Should concentrated potassium chloride be kept on wards at all?
Further reading
- (Saedder et al., 2014): identifies the drugs that matter most.
- (Cobaugh et al., 2013): practical insulin safety recommendations.
- (Zhong et al., 2016): large-scale test of Tall Man lettering.
- (Larmené-Beld et al., 2018): labelling strategies for look-alike errors.
- (Öztürk et al., 2022): Turkish tool for high-alert knowledge.
Glossary
| Turkish | English | Short definition |
|---|---|---|
| Yüksek riskli ilaç | High-alert medication | Drug with high harm potential in error |
| Görünüşü/okunuşu benzer ilaç | Look-alike, sound-alike drug | Drug easily confused with another |
| Tall Man yazımı | Tall Man lettering | Capitals emphasising name differences |
| Konsantre elektrolit | Concentrated electrolyte | For example concentrated potassium chloride |
| Renkli etiketleme | Colour-coded labelling | Visual warning on packages |
References
Al Rowily, A., Jalal, Z., Price, M. J., Abutaleb, M. H., Almodiaemgh, H., Al Ammari, M., & Paudyal, V. (2022). Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis. European Journal of Clinical Pharmacology, 78(4), 623-645. https://doi.org/10.1007/s00228-021-03212-y
Basco, W. T., Ebeling, M., Hulsey, T. C., & Simpson, K. (2010). Using Pharmacy Data to Screen for Look-Alike, Sound-Alike Substitution Errors in Pediatric Prescriptions. Academic Pediatrics, 10(4), 233-237. https://doi.org/10.1016/j.acap.2010.04.024
Chen, C. Y., Chen, Y. L., Scholl, J., Yang, H. C., & Li, Y. C. (2024). Ability of machine-learning based clinical decision support system to reduce alert fatigue, wrong-drug errors, and alert users about look alike, sound alike medication. Computer Methods and Programs in Biomedicine, 243, Article 107869. https://doi.org/10.1016/j.cmpb.2023.107869
Ciociano, N., & Bagnasco, L. (2014). Look alike/sound alike drugs: a literature review on causes and solutions. International Journal of Clinical Pharmacy, 36(2), 233-242. https://doi.org/10.1007/s11096-013-9885-6
Cobaugh, D. J., Maynard, G., Cooper, L., Kienle, P. C., Vigersky, R., Childers, D., Weber, R., Carson, S. L., Mabrey, M. E., Roderman, N., Blum, F., Burkholder, R., Dortch, M., Grunberger, G., Hays, D., Henderson, R., Ketz, J., Lemke, T., Varma, S. K., & Cohen, M. (2013). Enhancing insulin-use safety in hospitals: Practical recommendations from an ASHP Foundation expert consensus panel. American Journal of Health-System Pharmacy, 70(16), 1404-1413. https://doi.org/10.2146/ajhp130169
Donihi, A. C., Dinardo, M. M., Devita, M. A., & Korytkowski, M. T. (2006). Use of a standardized protocol to decrease medication errors and adverse events related to sliding scale insulin. Quality & Safety in Health Care, 15(2), 89-91. https://doi.org/10.1136/qshc.2005.014381
Dreijer, A. R., Diepstraten, J., Leebeek, F. W. G., Kruip, M. J. H. A., & Van Den Bemt, P. M. L. A. (2019). The effect of hospital-based antithrombotic stewardship on adherence to anticoagulant guidelines. International Journal of Clinical Pharmacy, 41(3), 691-699. https://doi.org/10.1007/s11096-019-00834-2
Dunn, E. B., & Wolfe, J. J. (2000). Finding an optimal dose: Considerations in accurate opioid dispensing. Veterinary and Human Toxicology, 42(1), 36-38.
Koyama, A. K., Maddox, C. S. S., Li, L., Bucknall, T., & Westbrook, J. (2020). Effectiveness of double checking to reduce medication administration errors: a systematic review. BMJ Quality & Safety, 29(7), 595-603. https://doi.org/10.1136/bmjqs-2019-009552
Larmené-Beld, K. H. M., Alting, E. K., & Taxis, K. (2018). A systematic literature review on strategies to avoid look-alike errors of labels. European Journal of Clinical Pharmacology, 74(8), 985-993. https://doi.org/10.1007/s00228-018-2471-z
Lohmeyer, Q., Schiess, C., Garcia, P. D. W., Petry, H., Strauch, E., Dietsche, A., Schuepbach, R. A., Buehler, P. K., & Hofmaenner, D. A. (2023). Effects of tall man lettering on the visual behaviour of critical care nurses while identifying syringe drug labels: a randomised in situ simulation. BMJ Quality & Safety, 32(1), 26-33. https://doi.org/10.1136/bmjqs-2021-014438
Morton, N. S., & Errera, A. (2010). APA national audit of pediatric opioid infusions. Pediatric Anesthesia, 20(2), 119-125. https://doi.org/10.1111/j.1460-9592.2009.03187.x
Öztornaci, B. Ö., & Basbakkal, Z. (2026). The Effect of Computerized Decision Support System in Preventing of High-risk Medication Errors in Pediatric Patients. Journal of Behcet Uz Childrens Hospital, 16(2), 108-119. https://doi.org/10.4274/jbuch.galenos.2026.26780
Öztürk, F., Altiparmak, Ö., Torun, B., Bektay, M. Y., Sancar, M., & Okuyan, B. (2022). Reliability of High-Alert Medications Questionnaire in Turkish Healthcare Professionals. Bezmialem Science, 10(1), 17-23. https://doi.org/10.14235/bas.galenos.2020.5238
Pearson, T. F., Pittman, D. G., Longley, J. M., Grapes, Z. T., Vigliotti, D. J., & Mullis, S. R. (1994). Factors associated with preventable adverse drug-reactions. American Journal of Hospital Pharmacy, 51(18), 2268-2272. https://doi.org/10.1093/ajhp/51.18.2268
Pirmammadova, F., Uzun, H. G., Mammadli, A., Urganci, A. C., Borna, Y., Rzayeva, A., Zoghi, M., Kayikçioglu, M., & Simsek, E. (2026). Assessment of Patients' Awareness of Anticoagulant Use in Atrial Fibrillation: A Cross-Sectional Survey. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 54(7), 606-615. https://doi.org/10.5543/tkda.2026.23942
Ruutiainen, H. K., Kallio, M. M., & Kuitunen, S. K. (2021). Identification and safe storage of look-alike, sound-alike medicines in automated dispensing cabinets. European Journal of Hospital Pharmacy, 28(E1), E151-E156. https://doi.org/10.1136/ejhpharm-2020-002531
Saedder, E. A., Brock, B., Nielsen, L. P., Bonnerup, D. K., & Lisby, M. (2014). Identifying high-risk medication: a systematic literature review. European Journal of Clinical Pharmacology, 70(6), 637-645. https://doi.org/10.1007/s00228-014-1668-z
Sağlık Bakanlığı. (2020). Sağlıkta kalite standartları: Hastane (Sürüm 6.1). Sağlık Hizmetleri Genel Müdürlüğü, Sağlıkta Kalite, Akreditasyon ve Çalışan Hakları Dairesi Başkanlığı. https://dosyamerkez.saglik.gov.tr/Eklenti/41258/0/skshastane-seti-s-61–09082021pdf.pdf
Simpson, K. R., & Knox, G. E. (2009). Oxytocin as a high-alert medication: implications for perinatal patient safety. MCN: The American Journal of Maternal/Child Nursing, 34(1), 8-15. https://doi.org/10.1097/01.NMC.0000343859.62828.ee
Zhong, W. J., Feinstein, J. A., Patel, N. S., Dai, D. W., & Feudtner, C. (2016). Tall Man lettering and potential prescription errors: a time series analysis of 42 children's hospitals in the USA over 9 years. BMJ Quality & Safety, 25(4), 233-240. https://doi.org/10.1136/bmjqs-2015-004562
Zyoud, S. H., Khaled, S. M., Kawasmi, B. M., Habeba, A. M., Hamadneh, A. T., Anabosi, H. H., Fadel, A. B., Sweileh, W. M., Awang, R., & Al-Jabi, S. W. (2019). Knowledge about the administration and regulation of high alert medications among nurses in Palestine: a cross-sectional study. BMC Nursing, 18, Article 11. https://doi.org/10.1186/s12912-019-0336-0
Source verification and AI use statement
Source verification. All 22 references were generated programmatically from the Web of Science records of the corpus, so authors, year, title, journal and DOI match the records exactly; every in-text citation was cross-checked by code against the reference list. Claims were checked against the record abstracts; full texts were not read. The SKS Hospital Set (Version 6.1) is the only source outside the corpus; it was accessed and read for this chapter.
AI use statement. Claude (Anthropic) was used to merge and de-duplicate the Web of Science exports, assign records to sub-topics, compute the bibliometric indicators and figures, and draft the text under the author’s instructions. The author is responsible for the final content.
Data and supplementary material
Supplementary file S1 (Excel) lists the 310 records of this chapter (authors, year, title, journal, DOI, title match flag), together with the full screening log of the 4948-record corpus and the citation verification report. The list is not reproduced here; it is available from the author on request.
← Chapter 10: Pharmacovigilance and Adverse Drug Reactions in HospitalChapter 12: Controlled Substances and Drug Diversion →